{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:24:49Z","timestamp":1795101889085,"version":"4.10.3"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009193","name":"Royal Society of New Zealand Marsden Fund","doi-asserted-by":"publisher","award":["15-UOA-157"],"award-info":[{"award-number":["15-UOA-157"]}],"id":[{"id":"10.13039\/501100009193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009193","name":"Royal Society of New Zealand Marsden Fund","doi-asserted-by":"publisher","award":["15-UOA-003"],"award-info":[{"award-number":["15-UOA-003"]}],"id":[{"id":"10.13039\/501100009193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["16420"],"award-info":[{"award-number":["16420"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"Cure For MND Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001509","name":"Royal Society Te Ap\u0101rangi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","award":["21\/034"],"award-info":[{"award-number":["21\/034"]}],"id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nbd.2025.107127","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:47:35Z","timestamp":1758948455000},"page":"107127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementia"],"prefix":"10.1016","volume":"216","author":[{"given":"Kyrah M.","family":"Thumbadoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Nementzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly E.V.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger V.","family":"Dieriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dragunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.M.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice A.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Scotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107127_bb0005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41582-023-00878-z","article-title":"Neuropsychological impairment in amyotrophic lateral sclerosis\u2013frontotemporal spectrum disorder","volume":"19","author":"Abrahams","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2025.107127_bb0015","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1874220302007010025","article-title":"Early-onset of frontotemporal dementia and amyotrophic lateral sclerosis in an Albanian patient with a c.1319C>T variant in the UBQLN2 gene","volume":"7","author":"Baglivo","year":"2020","journal-title":"Open Med J"},{"key":"10.1016\/j.nbd.2025.107127_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/08919887221119976","article-title":"Living with frontotemporal degeneration: diagnostic journey, symptom experiences, and disease impact","volume":"36","author":"Barker","year":"2023","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2022.891841","article-title":"Editorial: cognitive and behavioral features in ALS: beyond motor impairment in ALS-FTD Spectrum disorders","volume":"13","author":"Bersano","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/17482968.2012.706303","article-title":"Amyotrophic lateral sclerosis: a hormonal condition?","volume":"13","author":"Blasco","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2025.107127_bb0040","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/brain\/awr195","article-title":"Motor neuron dysfunction in frontotemporal dementia","volume":"134","author":"Burrell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107127_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae011","article-title":"Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum","author":"Carbayo","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107127_bb0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107127_bb0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40478-018-0627-9","article-title":"Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats","volume":"6","author":"Chen","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.107127_bb0060","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1212\/WNL.0000000000005996","article-title":"The multistep hypothesis of ALS revisited","volume":"91","author":"Chi\u00f2","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107127_bb0065","doi-asserted-by":"crossref","first-page":"e802","DOI":"10.1212\/WNL.0000000000008869","article-title":"ALS phenotype is influenced by age, sex, and genetics: a population-based study","volume":"94","author":"Chi\u00f2","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107127_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaz5677","article-title":"A second X chromosome contributes to resilience in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2025.107127_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"issue":"1711","key":"10.1016\/j.nbd.2025.107127_bb0080","article-title":"Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients","volume":"34","author":"Dillen","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12041-015-0574-1","article-title":"X-chromosome inactivation and escape","volume":"94","author":"Disteche","year":"2015","journal-title":"J. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the \u03b1-galactosidase a gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.nbd.2025.107127_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0100","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107127_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-024-10240-2","article-title":"Identification of skewed X chromosome inactivation using exome and transcriptome sequencing in patients with suspected rare genetic disease","volume":"25","author":"Fadra","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.nbd.2025.107127_bb0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.24164","article-title":"UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration","volume":"75","author":"Fahed","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2019.00219","article-title":"X inactivation and escape: epigenetic and structural features","volume":"7","author":"Fang","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.nbd.2025.107127_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp-2012-303433","article-title":"Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia","volume":"84","author":"Gellera","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"229","key":"10.1016\/j.nbd.2025.107127_bb0125","first-page":"e5","article-title":"Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia","volume":"73","author":"Gkazi","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0130","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/CON.0000000000000535","article-title":"Diagnosis and clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders","volume":"23","author":"Goutman","year":"2017","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"10.1016\/j.nbd.2025.107127_bb0135","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev."},{"key":"10.1016\/j.nbd.2025.107127_bb0140","article-title":"Increased Ubqln2 expression causes neuron death in transgenic rats","volume":"285\u2013293","author":"Huang","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107127_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-024-00416-x","article-title":"Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications","volume":"13","author":"Huang","year":"2024","journal-title":"Transl. Neurodegen."},{"key":"10.1016\/j.nbd.2025.107127_bb0150","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gr.210609.116","article-title":"Genetic compendium of 1511 human brains available through the UK Medical Research Council brain banks network resource","volume":"27","author":"Keogh","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.nbd.2025.107127_bb0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","article-title":"The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease","volume":"98","author":"Keum","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/hmg\/ddx403","article-title":"Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS","volume":"27","author":"Kim","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-022-02934-z","article-title":"Recent updates on the genetics of amyotrophic lateral sclerosis and frontotemporal dementia","author":"Kirola","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107127_bb0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5152\/npa.2016.12371","article-title":"A Turkish family with a familial ALS-positive UBQLN2-S340I mutation","volume":"53","author":"Kotan","year":"2016","journal-title":"Noropsikiyatri Arsivi"},{"issue":"2078","key":"10.1016\/j.nbd.2025.107127_bb0185","article-title":"Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients","volume":"34","author":"Lattante","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0195","doi-asserted-by":"crossref","first-page":"W222","DOI":"10.1093\/nar\/gkx313","article-title":"PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update","volume":"45","author":"L\u00f3pez-Ferrando","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107127_bb0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ajmg.1320400323","article-title":"Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy","volume":"40","author":"Lupski","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107127_bb0210","first-page":"135","article-title":"Sex chromatin and gene action in the mammalian X-chromosome","volume":"14","author":"Lyon","year":"1962","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S0016672300003451","article-title":"Attempts to test the inactive-X theory of dosage compensation in mammals","volume":"4","author":"Lyon","year":"1963","journal-title":"Genet. Res."},{"key":"10.1016\/j.nbd.2025.107127_bb0220","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1038\/ncomms11843","article-title":"Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome","volume":"7","author":"Machiela","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107127_bb0225","first-page":"57","article-title":"Variation in world wide incidence of amyotrophic lateral sclerosis: a meta-analysis","volume":"46","author":"Marin","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.nbd.2025.107127_bb0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41598-023-50668-2","article-title":"Unfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant","volume":"14","author":"Matsumoto","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107127_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmedgenet-2020-106866","article-title":"Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis","volume":"58","author":"McCann","year":"2021","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"issue":"267","key":"10.1016\/j.nbd.2025.107127_bb0245","article-title":"UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland","volume":"35","author":"McLaughlin","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0250","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41436-020-0779-4","article-title":"X-linked diseases: susceptible females","volume":"22","author":"Migeon","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.nbd.2025.107127_bb0255","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/brain\/awx082","article-title":"A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK","volume":"140","author":"Morgan","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107127_bb0260","doi-asserted-by":"crossref","first-page":"103e","DOI":"10.1136\/jmg.40.8.e103","article-title":"Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers","volume":"40","author":"Morrone","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bpa.13230","article-title":"Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia","volume":"34","author":"Nementzik","year":"2024","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2025.107127_bb0270","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107127_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34620-y","article-title":"The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration","volume":"13","author":"Opie-Martin","year":"2022","journal-title":"Nat. Commun."},{"issue":"1764","key":"10.1016\/j.nbd.2025.107127_bb0280","article-title":"The distinct genetic pattern of ALS in Turkey and novel mutations","volume":"36","author":"\u00d6zo\u011fuz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/21678421.2014.903974","article-title":"Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)","volume":"15","author":"Paganoni","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.nbd.2025.107127_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19669-x","article-title":"Inferring the molecular and phenotypic impact of amino acid variants with MutPred2","volume":"11","author":"Pejaver","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107127_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2025.107127_bb0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107127_bb0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"214","key":"10.1016\/j.nbd.2025.107127_bb0315","first-page":"e1","article-title":"C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue","volume":"49","author":"Scotter","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0320","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/01.wnl.0000319702.37497.72","article-title":"Distinct genetic forms of frontotemporal dementia","volume":"71","author":"Seelaar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107127_bb0325","article-title":"Do you know the sex of your cells?","volume":"306","author":"Shah","year":"2014","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.nbd.2025.107127_bb0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2025.107127_bb0335","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ncl.2015.07.006","article-title":"Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"issue":"W1","key":"10.1016\/j.nbd.2025.107127_bib411","doi-asserted-by":"crossref","first-page":"W446","DOI":"10.1093\/nar\/gkab266","article-title":"MutationTaster2021","volume":"49","author":"Steinhaus","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107127_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1391807","article-title":"X-chromosome inactivation and related diseases","volume":"2022","author":"Sun","year":"2022","journal-title":"Genet Res (Camb)"},{"issue":"2949","key":"10.1016\/j.nbd.2025.107127_bb0345","first-page":"e13","article-title":"Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype","volume":"33","author":"Synofzik","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0350","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp-2020-322987","article-title":"Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration","volume":"91","author":"Tavares","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"239","key":"10.1016\/j.nbd.2025.107127_bb0355","article-title":"Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis","volume":"58","author":"Teyssou","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0360","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/brain\/awae140","article-title":"Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"147","author":"Thumbadoo","year":"2024","journal-title":"Brain"},{"issue":"546","key":"10.1016\/j.nbd.2025.107127_bb0365","article-title":"A UBQLN2 variant of unknown significance in frontotemporal lobar degeneration","volume":"36","author":"Ugwu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0370","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng.3622","article-title":"Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis","volume":"48","author":"Van Rheenen","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.107127_bb0375","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/21678421.2013.824001","article-title":"Clinical variability and female penetrance in X-linked familial FTD\/ALS caused by a P506S mutation in UBQLN2","volume":"14","author":"Vengoechea","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.nbd.2025.107127_bb0380","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/nprot.2006.354","article-title":"Immunohistochemical staining of post-mortem adult human brain sections","volume":"1","author":"Waldvogel","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2025.107127_bb0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10561-008-9068-1","article-title":"The collection and processing of human brain tissue for research","volume":"9","author":"Waldvogel","year":"2008","journal-title":"Cell Tissue Bank."},{"issue":"2527","key":"10.1016\/j.nbd.2025.107127_bb0390","article-title":"UBQLN2\/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis","volume":"33","author":"Williams","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107127_bb0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuron.2013.10.051","article-title":"Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease","volume":"81","author":"Wu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107127_bb0400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-014-1367-y","article-title":"Pathogenic Ubqln2 gains toxic properties to induce neuron death","volume":"129","author":"Wu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107127_bb0405","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/acs.jpcb.9b01024","article-title":"Single amino acid substitutions in stickers, but not spacers, substantially Alter UBQLN2 phase transitions and dense phase material properties","volume":"123","author":"Yang","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.nbd.2025.107127_bb0410","article-title":"Impaired 26s proteasome assembly precedes neuronal loss in mutant ubqln2 rats","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:27:14Z","timestamp":1762028834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"alternative-id":["S0969996125003444"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107127","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107127"}}